FDA 483 - Actavis Laboratories UT, Inc. - August 20, 2021

An FDA inspection of Actavis Laboratories UT, a wholly owned subsidiary of Teva Pharmaceutical, in Salt Lake City, UT, from August 16-20, 2021, identified one observation. The firm was cited for failing to properly store and segregate labeling materials from other drug components. This indicates a deficiency in their packaging and labeling system.